Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia, Neutrophilic, Chronic

Clinical trial condition

Leukemia, Neutrophilic, Chronic

Explore clinical trials studying Leukemia, Neutrophilic, Chronic. Study availability and eligibility vary by location and protocol.

77 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Neutrophilic, Chronic trial results

Completed

Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder

NCT00049634

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +29 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

Seattle Cancer Care Alliance Seattle, Washington, United States

View Trial Details

Completed

Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

NCT00357084

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +100 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Campath-1H + FK506 and Methylprednisolone for GVHD

NCT00109993

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Mt. Sinai Medical Center New York, United States

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Oregon Health Sciences University Portland, Oregon, United States

View Trial Details

Completed

Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder

NCT00054340

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +31 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

NCT00410657

Conditions: Aberrant Motor Behavior in Dementia, Adnexal Diseases, Aggression, +109 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer

NCT00346359

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +32 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

NCT00096096

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +76 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details